Background: The sinoatrial node (SAN) has intricate architecture, which facilitates the spontaneous action potentials generated from the SAN to pace and drive the neighboring myocardium. We sought to create an engineered SAN that recapitulates the native SAN’s ability to overcome source-sink mismatch. We hypothesized spheroids consisting of induced pacemaker cells (iPM) can pace and drive surrounding quiescent myocardium. Methods: The iPMs were created by singular expression of a transcription factor, TBX18, to neonatal rat ventricular myocytes as we have previously demonstrated. The iPM or GFP-spheroids (control) were created by subjecting the NRVMs to the AggreWell™ plate at 1000 cells/well, and cultured for three days in suspension. Spheroids consisted of 90% NRVM and 10% cardiac fibroblast. Results: iPM-spheroids demonstrated spontaneous pacing at 145±26 bpm compared to 66±1 bpm (p=6.5770E-9) of control, GFP-spheroids. When one iPM-spheroid was surrounded by a monolayer of quiescent NRVMs (iPM:NRVM=1:100), the iPM-spheroids were able to pace and drive the quiescent ventricular myocardium at a capture rate of 48±7%. In contrast, the random activity of control spheroids captured the myocardium at 7±4% (p=0.0078). A monolayer of TBX18 cells (1:4=TBX18:NRVM) failed to pace and drive the neighboring sheet of ventricular myocytes. iPM-spheroids had a 17-fold increase in SAN-specific gap junction, Cx45, transcripts (p=0.0001) and a 2-fold decrease in myocardial gap junction, Cx43 (p=0.0030), compared to GFP-spheroids. The iPM-spheroids have superior viability compared to control GFP-spheroids, 87±1% and 72±5% respectively (p= 0.0463). TUNEL staining confirmed apoptotic fibroblast in the periphery. When cultured for >2 weeks, iPM-spheroids demonstrated small α-sarcomeric actinin positive cells organized as a mesh in the core, similar to the pacemaker cells in the native SAN. Conclusion: iPM-spheroids can pace and drive surrounding quiescent myocardium, overcoming the source-sink mismatch. The iPM-spheroids are viable in long-term and exhibit native SAN-like pacemaker cell organization. These data provide an in vitro platform on which the design principles of native SAN could be tested.